A
-
Alzheimer's Foundation of America
-
Alzheimer's Research Trust
-
Amarin Corporation
Amarin is a late clinical-stage biopharmaceutical company with a lead program planned to enter Phase 3 for hypertriglyceridemia. Amarin’s cardiovascular programs capitalize on its expertise in the field of lipid science and the known therapeutic benefits of essential fatty acids in cardiovascular disease. Amarin’s pipeline also includes programs in myasthenia gravis, Huntington’…
-
Ambiguous Genitalia Support Network
-
Ambiguous Genitalia Support Network
-
American Academy of Allergy, Asthma and Immunology
-
American Academy of Audiology
-
American Academy of Neurology
-
American Association for Klinefelter Syndrome Information and Support
-
American Association of Equine Practitioners